InspireMD Inc. (NSPR)
Symbol Info
Listed Symbol NSPR
Name InspireMD Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $3,601,000
Latest Fiscal EPS $-64.66
Price Info
21 Day Moving Average $2.7219
21 Day EMA $2.616490
50 Day Moving Average $3.1522
50 Day EMA $3.149010
200 Day EMA $21.117820
200 Day Moving Average 6.571400
52 Week High $15.34
52 Week Low $1.90
52 Week Change $-77.554100
Alpha -0.155205
Beta 1.8954
Standard Deviation 0.301847
R2 0.047466
Periods 60
Share Information
10 Day Average Volume 42,651
20 Day Average Volume 25,602
30 Day Average Volume 21,162
50 Day Average Volume 23,648
Outstanding Shares 1,398,271
Float Shares -
Percent Float -
Short Interest 111,852
Short Percent Float 8.00%
Short Interest Ratio 10.27
Short Date 2019-07-31
Holders
Institutions 10
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 143,775
Institute Holdings Percent 0.900000
Institute Sold Previous 3 Months -
Insider Holdings Date 2019-02-28
Insider Bought Previous 3 Months 3,185,000
Insider Holdings Percent -
Insider Sold Previous 3 Months 65
Insiders Shares Owned 14,553,698
Price Change
7 Day Price Change $-0.0101001
7 Day Percent Change -0.45%
21 Day Price Change $-0.9401002
21 Day Percent Change -29.75%
30 Day Price Change $-1.0101001
30 Day Percent Change -31.27%
Month To Date Price Change $-1.0901
Month To Date Percent -32.93%
90 Day Price Change $-1.0001
90 Day Percent Change -31.06%
Quarter To Date $-1.1901
Quarter To Date Percent -34.90%
180 Day Price Change $-7.7801
180 Day Percent Change -77.80%
200 Day Price Change $-7.5301
200 Day Percent Change -77.23%
Year To Date $-5.725101
Year To Date Percent -72.06%
Profile
Description InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.
Details
Issue Type CS
Market Cap $3,104,022
Sec Type EQS
Auditor Kesselman & Kesselman C.P.A.s
Total Shares Outstanding 1,398,271
CEO James J. Barry
Employees 43
Last Audit UE
Classification
CIK 0001433607
Industry Medical Devices
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 4 Menorat Hamaor Street
Tel Aviv, 6744832
Website http://www.inspiremd.com
Facisimile +972 36917692
Telephone +972 888776804
Email
Key Ratios
Profitability
EBIT Margin -282.7
EBITDA Margin -278.3
Pre-Tax Profit Margin -503.4
Profit Margin Cont -
Gross Margin 23.60
Profit Margin TOT -
Income Statements
Revenue $3,360,000
Revenue Per Share $2.4030
Revenue 3 Years $18.99
Revenue 5 Years $0.74
Valuation Measures
PE Ratio -
Enterprise Value $-833,580
Price To Sales 0.923816
Price To Free Cash -0.3
PE High Last 5 Years -
Price To Book 0.5
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.5
Financial Strength
Total Debt To Equity 0.2
Int Coverage -
Current Ratio 3.7
Leverage Ratio 1.5
Quick Ratio 0.6
Long Term Debt To Capital 0.16
Assets
Receivables Turnover 1.4
Invoice Turnover 2.80
Assets Turnover 0.20
Management Effectiveness
Return Assets -107.63
Return On Equity -208.71
Return On Capital -170.17
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
AMEX
NSPR
InspireMD
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.